Rita J. Guerreiro

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 148 publications

Exome analysis of 22,319 individuals links extremely rare copy-number variants and 22q11.21 dosage to Alzheimer risk.

Exome analysis of 22,319 individuals links extremely rare copy-number variants and 22q11.21 dosage to Alzheimer risk.

Journal: American journal of human genetics

Published: April 20, 2026

Maternal Longevity is Associated With Reduced Risk but an Earlier Onset of Alzheimer's Disease in Offspring.

Maternal Longevity is Associated With Reduced Risk but an Earlier Onset of Alzheimer's Disease in Offspring.

Journal: Journal of geriatric psychiatry and neurology

Published: February 16, 2026

Exploring cerebral small vessel disease signatures in familial Parkinson's disease.

Exploring cerebral small vessel disease signatures in familial Parkinson's disease.

Journal: Scientific reports

Published: July 02, 2025

Domain mapping of disease mutations reveals pathogenic SORL1 variants in Alzheimer's disease.

Domain mapping of disease mutations reveals pathogenic SORL1 variants in Alzheimer's disease.

Journal: Molecular neurodegeneration

Published: February 20, 2025

Ide Copy Number Variant Does Not Influence Stroke Severity in 2 C57BL/6J Mouse Models nor in Humans: An Exploratory Study.

Ide Copy Number Variant Does Not Influence Stroke Severity in 2 C57BL/6J Mouse Models nor in Humans: An Exploratory Study.

Journal: Stroke

Published: January 27, 2025

Communication in Neonatal Intensive Care: Translation and Validation of the "Parents' Experiences of Communication in Neonatal Care" Questionnaire for the Portuguese Population.

Communication in Neonatal Intensive Care: Translation and Validation of the "Parents' Experiences of Communication in Neonatal Care" Questionnaire for the Portuguese Population.

Journal: Acta medica portuguesa

Published: December 19, 2024

Genome-wide association analysis identifies APOE as a mitophagy modifier in Lewy body disease.

Genome-wide association analysis identifies APOE as a mitophagy modifier in Lewy body disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: December 13, 2024

Exome sequencing of a Portuguese cohort of early-onset Alzheimer's disease implicates the X-linked lysosomal gene GLA.

Exome sequencing of a Portuguese cohort of early-onset Alzheimer's disease implicates the X-linked lysosomal gene GLA.

Journal: Scientific reports

Published: September 19, 2024

Exploring first-degree family history in a cohort of Portuguese Alzheimer's disease patients: population evidence for X-chromosome linked and recessive inheritance of risk factors.

Exploring first-degree family history in a cohort of Portuguese Alzheimer's disease patients: population evidence for X-chromosome linked and recessive inheritance of risk factors.

Journal: Journal of neurology

Published: July 22, 2024

Genome-wide association study of neuropathological features in Lewy body disease.

Genome-wide association study of neuropathological features in Lewy body disease.

Journal: Brain : a journal of neurology

Published: May 09, 2024

Genome-wide association study identifies APOE and ZMIZ1 variants as mitophagy modifiers in Lewy body disease.

Genome-wide association study identifies APOE and ZMIZ1 variants as mitophagy modifiers in Lewy body disease.

Journal: medRxiv : the preprint server for health sciences

Published: October 31, 2023

Lysosomal polygenic risk is associated with the severity of neuropathology in Lewy body disease.

Lysosomal polygenic risk is associated with the severity of neuropathology in Lewy body disease.

Journal: Brain : a journal of neurology

Published: January 20, 2023

Showing 1-12 of 148

Last Updated: 09/26/2026